Personal information

No personal information available

Activities

Employment (1)

Metaphasis Theratech SmPC: Kifisia, Attiki, GR

2014 to present | CEO (Biotechnology and Pharmacology research)
Employment
Source: Self-asserted source
Nikolaos Nikoleousakos

Education and qualifications (3)

Ethniko kai Kapodistriako Panepistemio Athenon Iatrike Schole: Athens, Attiki, GR

2014-02-06 to 2022-07-06 | PhD (Pharmacology (cancer))
Education
Source: Self-asserted source
Nikolaos Nikoleousakos

IIEK KSINIS: Piraeus, Attika, GR

2013 to 2015 | Computer Network technician (Mechanical engineering)
Education
Source: Self-asserted source
Nikolaos Nikoleousakos

University of Thessaly: Larissa, Larissa, GR

2006 to 2013 | BSc (Biochemistry and Biotechnology)
Education
Source: Self-asserted source
Nikolaos Nikoleousakos

Works (7)

Cytocidal Antitumor Effects against Human Ovarian Cancer Cells Induced by B-Lactam Steroid Alkylators with Targeted Activity against Poly (ADP-Ribose) Polymerase (PARP) Enzymes in a Cell-Free Assay

Biomedicines
2021-08-17 | Journal article
Contributors: Nikolaos Nikoleousakos; Panagiotis Dalezis; Aikaterini Polonifi; Elena G. Geromichalou; Sofia Sagredou; Constantinos E. Alifieris; Maria V. Deligiorgi; Vasiliki Sarli; Dimitrios T. Trafalis
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Anticancer Activity of Triazolo-Thiadiazole Derivatives and Inhibition of AKT1 and AKT2 Activation

Pharmaceutics
2021-04-05 | Journal article
Contributors: Dimitrios T. Trafalis; Sofia Sagredou; Panayiotis Dalezis; Maria Voura; Stella Fountoulaki; Nikolaos Nikoleousakos; Konstantinos Almpanakis; Maria V. Deligiorgi; Vasiliki Sarli
Source: check_circle
Crossref

3,6-Disubstituted 1,2,4-Triazolo[3,4-b]Thiadiazoles with Anticancer Activity Targeting Topoisomerase II Alpha.

OncoTargets and therapy
2020-07 | Journal article
Contributors: Sagredou S; Dalezis P; Nikoleousakos N; Nikolaou M; Voura M; Almpanakis K; Panayiotidis MI; Sarli V; Trafalis DT
Source: Self-asserted source
Nikolaos Nikoleousakos via Europe PubMed Central

Azasteroid Alkylators as Dual Inhibitors of AKT and ERK Signaling for the Treatment of Ovarian Carcinoma

Cancers
2020-05-16 | Journal article
Contributors: Panagiotis Dalezis; Eleni Geromichalou; Aikaterini Polonifi; Sofia Sagredou; Nikolaos Nikoleousakos; Michael Nikolaou; Vasiliki Sarli; Mihalis I. Panayiotidis; Dimitrios T. Trafalis
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Targeting on poly(ADP-ribose) polymerase activity with DNA-damaging hybrid lactam-steroid alkylators in wild-type and BRCA1-mutated ovarian cancer cells.

Chemical biology & drug design
2017-05 | Journal article
Contributors: Trafalis DT; Polonifi A; Dalezis P; Nikoleousakos N; Katsamakas S; Sarli V
Source: Self-asserted source
Nikolaos Nikoleousakos via Europe PubMed Central

Synthesis and evaluation of new steroidal lactam conjugates with aniline mustards as potential antileukemic therapeutics.

Steroids
2016-07 | Journal article
Contributors: Trafalis D; Geromichalou E; Dalezis P; Nikoleousakos N; Sarli V
Source: Self-asserted source
Nikolaos Nikoleousakos via Europe PubMed Central

The σ-hole phenomenon of halogen atoms forms the structural basis of the strong inhibitory potency of C5 halogen substituted glucopyranosyl nucleosides towards glycogen phosphorylase b.

ChemMedChem
2012-01 | Journal article
Contributors: Kantsadi AL; Hayes JM; Manta S; Skamnaki VT; Kiritsis C; Psarra AM; Koutsogiannis Z; Dimopoulou A; Theofanous S; Nikoleousakos N et al.
Source: Self-asserted source
Nikolaos Nikoleousakos via Europe PubMed Central